Vir Biotechnology Inc (NASDAQ: VIR) established initial surge of 2.21% at $5.56, as the Stock market unbolted on Thursday, before settling in for the price of $5.44 at the close. Taking a more long-term approach, VIR posted a 52-week range of $4.16-$14.45.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -18.74%. Meanwhile, its Annual Earning per share during the time was -18.74%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 9.04%. This publicly-traded company’s shares outstanding now amounts to $139.02 million, simultaneously with a float of $93.08 million. The organization now has a market capitalization sitting at $773.53 million. At the time of writing, stock’s 50-day Moving Average stood at $5.60, while the 200-day Moving Average is $5.87.
Vir Biotechnology Inc (VIR) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Vir Biotechnology Inc industry. Vir Biotechnology Inc’s current insider ownership accounts for 33.09%, in contrast to 54.23% institutional ownership. According to the most recent insider trade that took place on Nov 17 ’25, this organization’s EVP & Chief Financial Officer sold 6,799 shares at the rate of 5.56, making the entire transaction reach 37,782 in total value, affecting insider ownership by 110,701.
Vir Biotechnology Inc (VIR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
Vir Biotechnology Inc’s EPS increase for this current 12-month fiscal period is 9.04% and is forecasted to reach -2.93 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.14% through the next 5 years, which can be compared against the -18.74% growth it accomplished over the previous five years trading on the market.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Let’s observe the current performance indicators for Vir Biotechnology Inc (VIR). It’s Quick Ratio in the last reported quarter now stands at 7.25. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 45.88.
In the same vein, VIR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.62, a figure that is expected to reach -0.65 in the next quarter, and analysts are predicting that it will be -2.93 at the market close of one year from today.
Technical Analysis of Vir Biotechnology Inc (VIR)
Now, what If we examine the latest scores posted by [Vir Biotechnology Inc, VIR]. During the last 5-days, its volume was lower the volume of 1.53 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 59.49% While, its Average True Range was 49.38.
Raw Stochastic average of Vir Biotechnology Inc (VIR) in the period of the previous 100 days is set at 58.54%, which indicates a major fall in contrast to 64.50% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.33 that was higher than 0.30 volatility it exhibited in the past 100-days period.
